-
Sector Analysis
Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Neuromodulation Devices Market Report Overview The neuromodulation devices market size was valued at $6.06 billion in 2023. Factors such as deep brain stimulation and spinal cord stimulation will drive the market growth at a CAGR of more than 6% from 2023 to 2033. Neuromodulation is one of the fastest-growing medical device markets. Within the last 10 years, the market has grown exponentially, with spinal cord stimulation being the largest market. Neuromodulation Devices Market Outlook 2023-2033 ($ Billion) Buy Full Report...
-
Track & Monitor
Venture Capital Investments Q3 2023
GlobalData's Venture Capital Investments report provides detailed coverage of the global venture capital investment activity across sectors in Q3 2023, covering key insights and trends.
-
Product Insights
Vagus Nerve Stimulators (VNS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
VNS Pipeline Market Report Overview A VNS is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically implanted electrodes to target the vagus nerve. VNSs are utilized to treat neurological disorders like epilepsy and depression. The VNS pipeline market research report provides comprehensive information about the VNS pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Territories · The US...
-
Product Insights
VNS Property – Phraek Sa Industrial Estate – Samut Prakan
Equip yourself with the essential tools needed to make informed and profitable decisions with our VNS Property - Phraek Sa Industrial Estate - Samut Prakan report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Neuromodulation Devices – LivaNova PLC – VNS THERAPY
GlobalData, the industry analysis specialist, has released its latest report: Neuromodulation Devices - LivaNova PLC - VNS THERAPY. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the...
-
Product Insights
NewInnovations in Vagus Nerve Stimulators (VNS) – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Vagus Nerve Stimulators (VNS) - Global Pipeline Summary" provides comprehensive information about the Vagus Nerve Stimulators (VNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Vagus Nerve Stimulators (VNS) report provides key information and data related to: Extensive coverage of the Vagus Nerve Stimulators (VNS) under development Review details of major pipeline products which include product description, licensing and collaboration...
-
Track & Monitor
Innovation in Cybersecurity: Decentralised identity framework
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Decentralised identity framework segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on the...
-
Product Insights
Rubella (German Measles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Rubella virus is transmitted by airborne droplets when infected people sneeze or cough. Its symptoms include fever, headache, stuffy or runny nose, inflamed, red eyes, aching joints and enlarged, tender lymph nodes at the base of the skull, the back of the neck, and behind the ears. The Rubella pipeline drugs market research report provides comprehensive information on the therapeutics under development for Rubella, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of...
-
Product Insights
Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Respiratory syncytial virus (RSV) infection infects the lungs and breathing passages. RSV commonly causes bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children less than one year of age. The Respiratory Syncytial Virus pipeline market research report provides comprehensive information on the therapeutics under development for Respiratory Syncytial Virus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological...
-
Sector Analysis
Neuromodulation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
The Neuromodulation Devices pipeline market research report provides comprehensive information about the Neuromodulation Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.